Health Care Industry
Industry: Email Alert RSS FeedGeneric oxycodone approved
OB/GYN News, March 1, 2006
Oxycodone extended release tablets (10 mg, 20 mg, and 40 mg) are indicated for the treatment of moderate to severe pain when continuous analgesia is needed for an extended period of time. The tablets are the generic equivalent of OxyContin (Purdue Pharma). For more information, contact Teva Pharmaceutical Industries Ltd. by visiting www.tevapharm.com.
COPYRIGHT 2006 International Medical News Group
COPYRIGHT 2008 Gale, Cengage Learning
Brought to you by CBS MoneyWatch.com
- 10 Best Places to Retire
- Companies with the Best 401(k) Plans
- Most Important Document for Your Heirs? It's Not Your Will
- Video: Should You Expect to Retire Rich?
- Over 50? Here's How to Get (and Keep) a Great Job
Most Recent Health Articles
- Shoulder the load: don't let your delts take a back seat. Cap off your v-taper with this well-rounded routine
- It's show time: be ready for your HD close-up in just four short weeks
- Grim repper: experience new muscle growth and fat loss—along with some pain—with this at-home high-rep program
- Taking sides: train unilaterally to topple strength plateaus while you torch your midsection
- The power within: scientific studies have shown that these six supplements possess benefits you never imagined
Most Recent Health Publications
Most Popular Health Articles
- Detox in 7 days: a detoux diet can help you shed up to 10 pounds and leave you feeling terrific. Our weeklong plan shows you how to lose the weight and keep it off - Cover story
- All about nightshades: explore the hidden hazards of your favorite food with macrobiotic nutritionist Lino Stanchich
- La anemia falciforme - causas y tratamiento
- The sour truth about apple cider vinegar - evaluation of therapeutic use
- Treat sinusitis naturally: breath easy and relieve sinus pressure with these remedies - Quick Fixes and Long-Term Solutions
Most Popular Health Publications
Content provided in partnership with http://findarticles.com/source//
Sponsored by Merrill Lynch